Analysis of Better For You Wellness Inc. (BFYW)
Better For You Wellness Inc. (BFYW) has been showing some interesting price movements and technical indicators in the recent days:
1. Price Movement:
- The price has been fluctuating between 0.00160 and 0.00240 in the past week.
- There was a significant price drop on May 29th, followed by a slight recovery in the following days.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been around 35.89 to 50.39, indicating a slightly oversold to neutral market sentiment.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have been negative, suggesting a bearish trend in the short term.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively stable around 0.0021 to 0.0024.
3. Overall Analysis:
- The price volatility and technical indicators suggest that BFYW is currently in a consolidation phase.
- Traders and investors may want to closely monitor the price levels and key support/resistance areas for potential trading opportunities.
- It would be advisable to wait for more confirmation from the technical indicators before making any significant trading decisions.
Please note that this analysis is based on historical data and technical indicators, and it's important to conduct further research and analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock outstanding is 15.33 billion shares, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, 200-day moving average of $181.04, and a 52-week range from $164.08 to $199.62.
Lastly, dividends and splits information indicates a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. Overall, the financial performance of the company in terms of revenue generation has been positive and shows a growth trend.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently positive, indicating that the company's core business operations are generating cash.
3. The company has been paying a significant amount in interest and income taxes each year.
4. Financing activities show a pattern of common stock repurchases and debt issuances/payments, with variations in the amounts each year.
5. Investing activities reflect significant investments in the sale and purchase of investments, as well as capital expenditures.
6. The end cash position has also been fluctuating, reaching its highest value in 2020.
These conclusions provide insights into the company's financial performance and management of cash flows over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40
4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40
Based on these estimates, we can see a generally positive trend in expected earnings per share both quarterly and annually, with the next year showing a higher average estimate compared to the current year. It's also worth noting the increase in the number of analysts providing estimates for the next quarter compared to the current quarter.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a steady but slightly slower growth trajectory in the future.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.MACD of BFYW